← Open Payments lookup

BRIAN FELLOWS: Open Payments

NPI 1548211659 · SALEM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,472 in 167 payments from 32 companies in 2025. Trend: 2023 $3,083 · 2024 $3,799 · 2025 $3,472

Food & beverage: $3,472
CompanyPaymentsAmount
ABBVIE INC.28$480
AstraZeneca Pharmaceuticals LP16$418
PFIZER INC.12$256
Lilly USA, LLC10$230
Otsuka America Pharmaceutical, Inc.10$203
Teva Pharmaceuticals USA, Inc.11$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$171
Bayer Healthcare Pharmaceuticals Inc.6$140
Boehringer Ingelheim Pharmaceuticals, Inc.7$129
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$128

Products named: REXULTI, VRAYLAR, JARDIANCE, AIRSUPRA, UBRELVY, CAPLYTA, Kerendia, AUSTEDO XR.

Industry payments across MA — which companies pay providers there.